Table 1 Characteristics of participants categorized by metabolic syndrome and NAFLD status
Characteristics | Metabolic syndrome (−) | Metabolic syndrome (+) | ||
|---|---|---|---|---|
NAFLD (−) | NAFLD (+) | NAFLD (−) | NAFLD (+) | |
Total number | 382 (67.3) | 186 (32.7) | 66 (33.7) | 130 (66.3) |
Age at diagnosis (years) | 50.02 ± 10.31 | 51.21 ± 11.96 | 49.92 ± 12.11 | 51.82 ± 12.31 |
BMI (kg/m2) | 22.42 ± 4.07 | 22.96 ± 4.26 | 24.81 ± 3.49 | 25.92 ± 4.23 |
SBP (mmHg) | 116.67 ± 20.27 | 120.58 ± 22.32 | 132.31 ± 20.12 | 133.32 ± 20.21 |
DBP (mmHg) | 76.62 ± 10.31 | 74.91 ± 11.31 | 77.91 ± 9.91 | 78.31 ± 10.02 |
Triglycerides (mmol/L) | 1.54 ± 1.87 | 1.62 ± 1.71 | 2.21 ± 1.55 | 2.52 ± 1.81 |
HDL (mmol/L) | 1.20 ± 0.312 | 1.28 ± 0.323 | 1.32 ± 0.372 | 1.33 ± 0.298 |
LDL (mmol/L) | 2.52 ± 1.19 | 2.61 ± 1.21 | 2.48 ± 1.02 | 2.50 ± 0.98 |
Fasting glucose (mmol/L) | 5.01 ± 3.11 | 5.09 ± 2.76 | 5.39 ± 3.51 | 5.50 ± 3.42 |
CEA (ng/ml) | 21.0 ± 101.4 | 22.7 ± 102.1 | 23.2 ± 98.7 | 22.7 ± 101.0 |
Differentiation | ||||
Well/moderate | 310 (81.2) | 149 (80.1) | 55 (83.3) | 102 (78.5) |
Poorly | 72 (18.8) | 37 (19.9) | 11 (16.7) | 28 (21.5) |
Stage | ||||
I | 68 (17.8) | 41 (22.0) | 11 (16.7) | 21 (16.2) |
II | 164 (42.9) | 87 (46.7) | 25 (37.8) | 47 (36.2) |
III | 150 (39.3) | 58 (31.2) | 30 (45.5) | 62 (47.6) |
Location | ||||
Ascending, transverse, and descending | 102 (26.7) | 40 (21.5) | 22 (33.3) | 36 (27.7) |
Sigmoid | 108 (28.3) | 54 (29.0) | 17 (25.8) | 32 (24.6) |
Rectum | 172 (45.0) | 92 (49.5) | 27 (40.9) | 62 (47.7) |